MedTrace Logo

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

NCT02056522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 357

Last updated 2020-11-18

No results posted yet for this study

Summary

The use of MDS to access the presence of melanoma in the skin.

Conditions

  • Skin Lesions

Sponsors & Collaborators

  • Orlucent, Inc

    lead INDUSTRY

Principal Investigators

  • Shokrey Kassis, MA · Head of Plastic Surgery

Eligibility

Min Age
21 Years
Max Age
97 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-04-30
Completion
2018-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056522 on ClinicalTrials.gov